The president has crowed about the billions of dollars collected so far from tariffs. That money could be at risk if the White House loses the legal battle.
Category: Regulation and Deregulation of Industry
-
Trump Has Made Himself Commander in Chief of the Chip Industry
President Trump has become the semiconductor sector’s leading decision maker, from new fees on exports to China to a brief demand for a C.E.O.’s firing.
-
Gaming Out the Price of a Trump Trade Deal With China
President Trump again delayed higher tariffs on Chinese goods. But his recent moves on computer chips have stoked fears he’s willing to give too much to reach an accord.
-
Trump Crypto Firm Announces $1.5 Billion Digital Coin Deal
A publicly traded tech firm, ALT5 Sigma, plans to sell $1.5 billion of shares to fund the purchase of a cryptocurrency created by World Liberty Financial, which the Trumps control.
-
Why Young Americans Dread Turning 26: Health Insurance Chaos
Young adults without jobs that provide insurance find that their options are limited and expensive. The problem is about to get worse.
-
Car Companies Are Paying Tariffs So You Don’t Have To
But automakers can’t absorb the cost forever and will soon begin to raise new car prices, analysts say.
-
New Tariff on ‘Transshipped’ Goods Mystifies Importers
The Trump administration levied a hefty tariff on goods that are moved through other countries, but it has not yet fully explained its plans.
-
Truck Companies Sour on California’s Strict Clean Air Rules
A deal designed to force compliance with tougher emissions standards is as risk after the Trump administration intervened.
-
California Supreme Court Requires New Review of Rooftop Solar Policy
The court revived a legal challenge to a 2022 regulation that significantly reduced the compensation utilities paid to owners of home solar systems for the electricity they sent to the grid.
-
Trump Signs Executive Order Clamping Down on ‘Debanking’
Mostly right-leaning groups have complained of forced bank account closures. The evidence is spotty.
-
How Ozempic Maker Novo Nordisk Lost Its Shine
The pioneering Danish drugmaker was once the most valuable company in Europe, but analysts say a number of missteps reversed its fortunes.